By Professor Roy Gary Beran

Journal articles

Beran RG, 2001, 'Adverse events in medical management - Vigabatrin as a paradigm of forensic responsibility with novel therapy', Medicine and Law, 20, pp. 329 - 335

Beran RG, 2001, 'Ethical dilemmas of potential adverse events', Medicine and Law, 20, pp. 385 - 391

Beran RG, 2001, 'The classification of epileptic seizures and syndromes', Medicine and Law, 20, pp. 543 - 546

Beran RG, 2001, 'The ethics of post-marketing surveillance of therapeutic agents', Medicine and Law, 20, pp. 587 - 594

Chan DK; Dunne MC; Wong A; Hu E; Hung WT; Beran RG, 2001, 'Pilot study of prevalence of Parkinson`s disease in Australia', Neuroepidemiology, 20, pp. 112 - 117

Beran RG, 2001, 'Serious complications with neck manipulation and informed consent', Medical Journal of Australia, 174, pp. 427 - 428, http://dx.doi.org/10.5694/j.1326-5377.2001.tb143362.x

Chan DK; Hung WT; Wong A; Hu E; Beran RG, 2001, 'Validating a screening questionnaire for parkinsonism in Australia', Focus on Parkinson's disease, 13, pp. 15 - 17

Beran RG; Schaefer A; Sachinwalla T, 2000, 'Serious complications with neck manipulation and informed consent', Medical Journal of Australia, 173, pp. 213 - 214, http://dx.doi.org/10.5694/j.1326-5377.2000.tb125606.x

Beran RG; Beran ME, 2000, 'Conduct of trials in private clinical practice', Epilepsia, 41, pp. 875 - 879, http://dx.doi.org/10.1111/j.1528-1157.2000.tb00256.x

Ghougassian DF; Beran RG, 2000, 'Facial pain as a presenting feature of intracebral haemorrhage', Journal of Clinical Neuroscience, 7, pp. 343 - 345, http://dx.doi.org/10.1054/jocn.1999.0236

Beran RG, 2000, 'The classification of epileptic seizures and syndromes', Medicine and Law, 19, pp. 753 - 756

Beran RG, 2000, 'The ethics of clinical research and the conduct of clinical drug trials: International comparisons and codes of conduct', Medicine and Law, 19, pp. 501 - 521

Chan DK; Hung WT; Wong AM; Beran RG, 2000, 'Validating a screening questionnaire for parkinsonism in Australia', Journal of Neurology Neurosurgery and Psychiatry, pp. 117 - 120

Beran RG, 1999, 'Economic analysis of epilepsy care', Epilepsia, 40, pp. 19 - 24, http://dx.doi.org/10.1111/j.1528-1157.1999.tb00943.x

Beran RG, 1999, 'The burden of epilepsy for the patient: The intangible costs', Epilepsia, 40, pp. 40 - 43, http://dx.doi.org/10.1111/j.1528-1157.1999.tb00946.x

Beran R; Pachlatko C, 1999, 'Vision for the future', Epilepsia, 40, pp. 55 - 56, http://dx.doi.org/10.1111/j.1528-1157.1999.tb00949.x

Chadwick D; Baldy-Moulinier J; Ben-Manachem E; Beran R; Bes A; Biermann LD; Bird JM; Boon L; Byrne E; Calandre EP; de Seijas EV; Tejerina JA; Canger R; Saltarelli A; Cartlidge NEF; Corston RN; Cosi V; Dellaportas C; Duncan J; Van Paesschen W; Dam M; Danta G; Gadot H; Gale AN; Gisselbrecht D; Gross M; Guldenpfennig WM; Haan J; Howell SJL; Venables GS; Jankovic J; Kälviäinen R; Riekkinen P; Kennedy K; Kramer G; Kritzinger PH; Manelis J; Michelucci R; Tassinari CA; Neufeld M; Pederson B; Pisani F; Reches A; Ried B; Saunders EACM; Somerville E; Spechio L; Neve LA; Tramacere L; Stefan H; Tartara A; Van As AD; Van Donsellar CA; Weber M; Wieser HG; Zaccara G; Gomez GT, 1999, 'Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: A multicentre randomised double-blind study', Lancet, 354, pp. 13 - 19, http://dx.doi.org/10.1016/S0140-6736(98)10531-7

Panayiotopoulos CP; Beran RG, 1999, 'Letter to the editor [3] (multiple letters)', Epilepsia, 40, pp. 1171, http://dx.doi.org/10.1111/j.1528-1157.1999.tb00840.x

Beran RG; Plunkett M; Holland GJ, 1999, 'Interface of epilepsy and sleep disorders', Seizure - European Journal of Epilepsy, pp. 97 - 102

Beran RG, 1999, 'Lamotrigine and valprate, pharmacodynamic inter-action.', Epilepsia, pp. 1172 - 1172

Beran RG, 1999, 'REPLY', Epilepsia, 40, pp. 1172 - 1172, http://dx.doi.org/10.1111/j.1528-1157.1999.tb00841.x

Beran RG; Berkovic SF; Dunagan FM; Vajda FJE; Danta G; Black AB; Mackenzie R, 1998, 'Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy', Epilepsia, 39, pp. 1329 - 1333, http://dx.doi.org/10.1111/j.1528-1157.1998.tb01332.x

Beran RG, 1998, 'Confidentiality and the management of patients with epilepsy who fail to comply with doctor's advice not to drive: A survey of medical/legal opinions in Australia', Seizure, 7, pp. 459 - 468, http://dx.doi.org/10.1016/S1059-1311(98)80003-4

Boba A; Beran RG, 1998, 'Letter to the editor [2] (multiple letters)', Epilepsia, 39, pp. 1018 - 1019

Beran RG; Gibson RJ, 1998, 'Aggressive behaviour in intellectually challenged patients with epilepsy treated with lamotrigine', Epilepsia, pp. 280 - 282

Beran RG; Plunkett M; Beran ME, 1998, 'Burden of epilepsy for the patient.', Epilepsia, pp. 75 - 75

Beran RG; Plunkett M; Beran ME, 1998, 'Conducting clinical trials in private practice.', Epilepsia, pp. 118 - 118

Mccaughey L; Banks GA; Beran RG, 1998, 'Dynamics of domain functioning in epilepsy (QOLIE).', Epilepsia, pp. 76 - 76

Beran RG; Bates PW; Berkovic SF; Black A; Deveraux J; Mcsherry B; Reuben W, 1998, 'Epilepsy, driving and law.', Epilepsia, pp. 117 - 117

Beran RG; Berry D; Plunkett M, 1998, 'Gabapentin Pharmacokinetics.', Epilepsia, pp. 68 - 68

Man BY; Brodie MJ; Kalvianen R; Beran RG; Kruse T; Lyby K, 1998, 'Laboratory variables in a comparative monotherapy drug trial with tiagabine (gabitril).', Epilepsia, pp. 65 - 65

Beran RG, 1998, 'REPLY', Epilepsia, 39, pp. 1019 - 1019, http://dx.doi.org/10.1111/j.1528-1157.1998.tb01457.x

Beran RG, 1998, 'Should there be an accredited ethics committee system for centralised review of multicentre clinical research?', Medical Journal of Australia, 168, pp. 174 - 176

Beran RG, 1998, 'Treatment of epilepsy with vigabatrin and afterwards.', Proceedings of the 12th World Conference on Medical Law, Vol 1, pp. 40 - 47

Beran RG; Currie J; Sandbach J; Plunkett M, 1998, 'Visual field restriction with new anti epileptic medication.', Epilepsia, pp. 6 - 6

Beran RG; Pachlatko C, 1997, 'Final report of the ILAE Commission on Economic Aspects of Epilepsy, 1994-1997', Epilepsia, 38, pp. 1359 - 1362, http://dx.doi.org/10.1111/j.1528-1157.1997.tb00076.x

Beran RG, 1997, 'Epilepsy should not be an accepted defence in criminal proceedings', Medicine and Law, 16, pp. 405 - 412

Fenwick P; Beran RG, 1997, 'Informed consent - Should Bolam be rejected?', Medicine and Law, 16, pp. 215 - 223

Beran RG, 1997, 'Shared care-responsibilities of the doctors', Medicine and Law, 16, pp. 235 - 243

Beran RG; Holland GJ; Yan KY, 1997, 'The use of CPAP in patients with refractory epilepsy', Seizure, 6, pp. 323 - 325, http://dx.doi.org/10.1016/S1059-1311(97)80081-7

Beran RG; Berkovic SF; Dunagan F; Vajda FJ, 1997, 'A controlled trial of lamotrigine in generalised epilepsy', Epilepsia, pp. 69 - 69

Beran RG; Gibson RJ, 1997, 'Aggression provoked by lamotrigine in patients with developmental delay', Epilepsia, pp. 68 - 68

Beran RG; Holland GJ; Yan KY, 1997, 'Dual diagnosis of epilepsy and sleep disorders - approach to management', Epilepsia, pp. 165 - 165

Beran RG; Pachlatko C, 1997, 'Final report of the ILAE Commission on Economic Aspects of Epilepsy, 1994-1997. International League Against Epilepsy.', Epilepsia, 38, pp. 1359 - 1362, http://dx.doi.org/10.1111/j.1528-1157.1997.tb00076.x

Beran RG, 1997, 'Professional privilege, driving and epilepsy, the doctor`s responsibility', Epilepsy Research, pp. 415 - 421

Mccaughey L; Banks GA; Beran RG, 1997, 'The casual dynamics by which domains associated with the quality of life of PWE function to determine a global QoLie assessment', Epilepsia, pp. 85 - 85

Banks GA; Mccaughey L; Beran RG, 1997, 'The Sydney inventory of medication and cognitive impact (SIMCI): an outcome measure of clinical trials', Epilepsia, pp. 61 - 61

Banks GA; Mccaughey L; Beran RG, 1997, 'The Sydney quality of life in epilepsy scales (SQOLIES): an outcome measure of clinical trials', Epilepsia, pp. 85 - 85

Beran RG; Holland GJ; Kwok Y, 1997, 'The use of CPAP in patients with refractory epilepsy', Seizure, pp. 1 - 3

Beran RG; Sheehan K, 1996, 'An appraisal of the clinical use of lamotrigine under the special access scheme', Journal of Clinical Neuroscience, 3, pp. 239 - 242, http://dx.doi.org/10.1016/S0967-5868(96)90057-0

Back to profile page